Werkgroep Cardiologische centra Nederland

ZEUS-CVOT (Recruiting)

Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation
Medicine
Ziltivekimab
Population
ASCVD
Phase
III
Starting year
2020